Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
GSK Biological's Investigational Malaria Vaccine 257049
BIOLOGICAL
2 trials
Sponsors
GlaxoSmithKline
Conditions
Malaria
Phase 2
Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants
Completed
NCT01231503
GlaxoSmithKline
Malaria
Start: 2011-01-13
End: 2014-12-23
Updated: 2018-08-15
Phase 3
Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children
Completed
NCT01148459
GlaxoSmithKline
Malaria
Start: 2010-07-30
End: 2013-05-24
Updated: 2019-01-16
Related Papers
Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial.
2016-07-07
27 citations
Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa.
2011-08-04
50 citations